Table 1.
Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects
| Study group | Number of patients | |
|---|---|---|
| Epithelial ovarian cancer patients | 100 (100%) | |
| • median age (range) | 59 (46–87) | |
| - sub-type serous epithelial | 54 (54%) | |
| • median age (range) | 59 (46–81) | |
| - sub-type endometrioid epithelial | 46 (46%) | |
| • median age (range) | 59 (49–87) | |
| Tumor stage | IA-T1aN0M0 | 5 (5%) |
| IB-T1bN0M0 | 7 (7%) | |
| IC-T1cN0M0 | 13 (13%) | |
| IIA-T2aN0M0 | 8 (8%) | |
| IIB-T2bN0M0 | 9 (9%) | |
| IIC-T2cN0M0 | 8 (8%) | |
| IIIA-T3aN0M0 | 9 (9%) | |
| IIIB-T3bN0M0 | 9 (9%) | |
| IIIC-T3cN0M0 | 7 (7%) | |
| IV(metastases) | 25 (25%) | |
| Menopausal status: | ||
| - postmenopausal | 100 (100%) | |
| Benign ovarian tumor patients | 80 (100%) | |
| - type cystis serous | 40 (50%) | |
| - type cystis endometriosis | 40 (50%) | |
| Median age (range) | 54 (48–68) | |
| Menopausal status: | ||
| - postmenopausal | 80 (100%) | |
| Healthy subjects | 80 (100%) | |
| Median age (range) | 55 (47–64) | |
| Menopausal status: | ||
| - postmenopausal | 80 (100%) | |